title: Inducible nitric oxide synthase (iNOS) expression in liver and splenic T lymphocyte rise are associated with liver histological damage during experimental hepatitis A virus (HAV) infection in Callithrix jacchus.
abstract: Callithrix jacchus is considered a reliable animal model for hepatitis A virus (HAV) infection. All three HAV orally inoculated marmosets developed hepatitis - the infection was monitored by continuous virus shedding, high levels of serum enzyme alanine aminotransferase, specific antibody and seroconversion 3-6 weeks after HAV inoculation. HAV antigen was detected in liver by immunofluorescence 4 days post inoculation (PI) and onwards. To gain insight into the biological role of inducible nitric oxide synthase (iNOS) during immune-related acute liver injury the enzyme was searched in frozen biopsies: immunofluorescent labeling was found in the cytoplasm of liver cells mainly Kupffer's cells and spleen macrophages (CD68+) starting 11 days PI with maximum intensity on the fifth to sixth week PI. Necroinflammatory liver lesions characteristic of viral hepatitis were also observed at 10 days PI with maximum severity at 4 to 6 weeks PI. Furthermore, T lymphocytes (CD2+) were raised at this time point. No difference was evident in the frequency of B lymphocytes (CD20+). Therefore, iNOS expression preceded necroinflammatory liver lesion and maximal immunofluorescence reaction was coincident with tissue injury, supporting the hypothesis that NO contributes to hepatic cytotoxic mechanism but also to virus clearance. The concomitant rise in T-lymphocyte population may suggest a role for these cells in this and/or other independent HAV-induced pathological changes.
authors.affiliation: Department of Virology, IOC/FIOCRUZ, Rio de Janeiro, Brazil. marcelo@gene.dbbm.fiocruz.br
authors.forename: M A
authors.initials: MA
authors.lastname: Pinto
authors.forename: R S
authors.initials: RS
authors.lastname: Marchevsky
authors.forename: M
authors.initials: M
authors.lastname: Pelajo-Machado
authors.forename: M A
authors.initials: MA
authors.lastname: Santiago
authors.forename: J W
authors.initials: JW
authors.lastname: Pissurno
authors.forename: M S
authors.initials: MS
authors.lastname: França
authors.forename: M L
authors.initials: ML
authors.lastname: Baptista
authors.forename: A S
authors.initials: AS
authors.lastname: Gouvea
authors.forename: A A
authors.initials: AA
authors.lastname: Santana
authors.forename: A L
authors.initials: AL
authors.lastname: Bertho
authors.forename: H G
authors.initials: HG
authors.lastname: Schatzmayr
authors.forename: A M
authors.initials: AM
authors.lastname: Gaspar
authors.forename: C F
authors.initials: CF
authors.lastname: Kubelka
mesh_terms: D000818:Animals; D002144:Callithrix; D004195:Disease Models, Animal; D004790:Enzyme Induction; D005455:Fluorescent Antibody Technique; D006506:Hepatitis A / Q000201:enzymology* / Q000473:pathology; D006507:Hepatovirus; D016130:Immunophenotyping; D008099:Liver / Q000201:enzymology / Q000473:pathology* / Q000821:virology; D009336:Necrosis; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D052247:Nitric Oxide Synthase Type II; D013154:Spleen / Q000821:virology; D013601:T-Lymphocytes / Q000276:immunology* / Q000821:virology
chemical_list: D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II